NeuBase Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q2 2021 to Q3 2022

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary: NeuBase Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q2 2021 to Q3 2022.
NeuBase Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2022 was $2.12M, a 17% decline year-over-year.

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2022	$2.12M	-$436K	-17%	Sep 30, 2022	10-K	2022-12-21
Q4 2021	$2.45M			Dec 31, 2021	10-Q	2022-02-11
Q3 2021	$2.56M			Sep 30, 2021	10-K	2021-12-23
Q2 2021	$2.67M			Jun 30, 2021	10-Q	2021-08-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.